Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE study

Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE study

Abstract Background Patient adherence to treatment is key to preventing the worsening of neurological disability in multiple sclerosis (MS). The RebiSmart® autoinjector facilitates self-administration of subcutaneous interferon β-1a (sc IFN β-1a) and records objective adherence data. The CORE study...

Full description

Bibliographic Details
Main Authors: Chiara Zecca, Giulio Disanto, Sarah Mühl, Claudio Gobbi
Format: Article
Language:English
Published: BMC 2017-09-01
Series:BMC Neurology
Subjects:
Multiple sclerosis
RebiSmart®
Autoinjector
Subcutaneous interferon β-1a
sc IFN β-1a
Adherence
Online Access:http://link.springer.com/article/10.1186/s12883-017-0952-9

Internet

http://link.springer.com/article/10.1186/s12883-017-0952-9

Similar Items